• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. FEMORAL HEAD BIOLOX DELTA CERAMIC 12/14 - 36 M

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. FEMORAL HEAD BIOLOX DELTA CERAMIC 12/14 - 36 M Back to Search Results
Model Number PHA04416
Device Problem Insufficient Information (3190)
Patient Problem No Information (3190)
Event Type  Injury  
Manufacturer Narrative
This event will be updated when investigation is complete.
 
Event Description
Allegedly, patient was revised due to unknown.
 
Manufacturer Narrative
See investigation attached.- attachment: [ripojuly2019signed.Pdf, timingletter19070464.Pdf].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FEMORAL HEAD BIOLOX DELTA CERAMIC 12/14 - 36 M
Type of Device
HEAD
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key9721126
MDR Text Key180725157
Report Number3010536692-2019-00982
Device Sequence Number1
Product Code HRY
UDI-Device IdentifierM684PHA044161
UDI-PublicM684PHA044161
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 02/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberPHA04416
Device Catalogue NumberPHA04416
Device Lot Number048561090
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date07/02/2019
Initial Date Manufacturer Received 07/02/2019
Initial Date FDA Received02/18/2020
Supplement Dates Manufacturer Received07/02/2019
Supplement Dates FDA Received02/18/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-